Barbara Szczepańska

Dr. Barbara Szczepańska

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
MPMonika Pazgan-Simon
Monika Pazgan-Simon
KSKrzysztof Simon
Krzysztof Simon
TŁTadeusz Łapiński
Tadeusz Łapiński
Dorota Zarębska-MichalukDorota Zarębska-Michaluk
Dorota Zarębska-Michaluk
Robert FlisiakRobert Flisiak
Robert Flisiak
The clinical trials of the COVID-19 vaccines that are authorized in the European Union have revealed high efficacy in preventing symptomatic infections. However, during vaccination campaigns, some vaccine recipients, including those partially and fully vaccinated, will experience severe COVID-19, requiring hospitalization. This may particularly concern patients with a diminished immune response to the vaccine, as well as non-responders. This work has retrospectively analyzed the 92 cases of patients who were hospitalized between 27 December 2020 and 31 May 2021 in four Polish healthcare units due to COVID-19, and who have previously received the COVID-19 vaccine (54.3% ≤ 14 days after the first dose, 26.1% > 14 days after the first dose, 7.6% ≤ 14 days after the second dose, and 12% > 14 days after the second dose). These patients represented a minute fraction (1.2%) of all the COVID-19 patients who were hospitalized during the same period in the same healthcare institutions. No significant differences in white blood count, absolute lymphocyte count nadir, C-reactive protein, interleukin-6, procalcitonin, oxygen saturation, lung involvement, and fever frequency were found between the recipients of the first and second vaccine dose. A total of 15 deaths were noted (1.1% of all fatal COVID-19 cases in the considered period and healthcare units), including six in patients who received the second dose (five > 14 days after the second dose)—three of these subjects were using immunosuppressive medicines, and two were confirmed to be vaccine non-responders. The study reassures that severe COVID-19 and deaths are not common in vaccinated individuals, highlights that the clinical course in such patients may not reveal any distinctive features, and advocates for close monitoring of those at a higher risk of vaccine failure.

28 October 2021 in Infectious Diseases
Verified
Journal Article
Closed access
Anna ManiaAnna Mania
Anna Mania
Maria Pokorska-ŚpiewakMaria Pokorska-Śpiewak
Maria Pokorska-Śpiewak
MFMagdalena Figlerowicz
Magdalena Figlerowicz
MPMałgorzata Pawłowska
Małgorzata Pawłowska
Katarzyna Mazur-MelewskaKatarzyna Mazur-Melewska
Katarzyna Mazur-Melewska
Magdalena M MarczyńskaMagdalena M Marczyńska
Magdalena M Marczyńska
Although COVID-19 is associated with a mild course in children, a certain proportion requires admission to hospital due to SARS-CoV-2 infection and coexisting diseases. The prospective multicenter ...

19 March 2021 in Annals of Agricultural and Environmental Medicine
Verified
Journal Article
Open access
IPIlona Pałyga-Bysiecka
Ilona Pałyga-Bysiecka
BKBeata Kręcisz
Beata Kręcisz
BSBarbara Szczepańska
Barbara Szczepańska
Introduction: Tick-borne encephalitis (TBE) is a neurotropic, tick-transmitted infection. Clinical presentation ranges from mild aseptic meningitis to severe encephalitis, and may result in long-term neurological sequels. Objective: The aim of the study is to present the clinical features of...

17 October 2026 in Virology
Verified
Journal Article
Open access
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
IMIlona Małecka
Ilona Małecka
BSBarbara Szczepańska
Barbara Szczepańska
ZWZuzanna Wasielewska
Zuzanna Wasielewska
MPMałgorzata Pawłowska
Małgorzata Pawłowska
Dorota Zarębska-MichalukDorota Zarębska-Michaluk
Dorota Zarębska-Michaluk

13 December 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
Krystyna DobrowolskaKrystyna Dobrowolska
Krystyna Dobrowolska
MPMałgorzata Pawłowska
Małgorzata Pawłowska
Dorota Zarębska-MichalukDorota Zarębska-Michaluk
Dorota Zarębska-Michaluk
BSBarbara Szczepańska
Barbara Szczepańska
PCPrzemysław Ciechanowski
Przemysław Ciechanowski
Robert FlisiakRobert Flisiak
Robert Flisiak
This multicenter retrospective study was designed to track changes in the clinical presentation of COVID-19 in children that occurred in the last two infec